Charles River Laboratories, William Blair
Charles River Laboratories Stock Falls 6% on Dim FY25 Outlook
Shares for Charles River Laboratories slipped after the company said it expects revenue to decline in 2025. Shares of the Massachusetts-based pharmaceutical company were recently down 6% to $178.50 in morning trading. The stock is about 35% below its 52-week peak of $275.
Charles River Laboratories International ... The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services ...
Wilmington, Massachusetts-based Charles River Laboratories International, Inc. (CRL) provides drug discovery, non-clinical ...
Transgel (Charles River Laboratories) contains ∼70% water ... pack provides a 1-week supply for five adult mice. Napa Nectar Plus includes fenbendazole for the treatment of pinworms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback